Gazelles, unicorns, and dragons battle cancer through the Nanotechnology Startup Challenge

Gazelles, unicorns, and dragons battle cancer through the Nanotechnology Startup Challenge

On March 4th, 2016, Springer's Cancer Nanotechnology office promoted the launch of the Nanotechnology Startup Challenge in Cancer (NSC2 ). This innovation-development model is a partnership among our company, the Center for Advancing Innovation (CAI), MedImmune, the global biologics arm of AstraZeneca, and multiple institutes at the National Institutes of Health (NIH). NSC2 "crowdsources" talen...

Cancer Nanotechnology Startup Challenge: a new way to realize the fruits of innovation

A significant new innovation-development model is being launched in the field of cancer and nanotechnology. A significant new innovation-development model is being launched in the field of cancer and nanotechnology.

Ultrasound in Cancer Treatment through Nanotechnology

ultrasound in cancer treatment through nanotechnology

0

Ultrasound in Cancer Treatment through Nanotechnology

*Corresponding author: A. Shakeri-Zadeh, Ph.D. Medical Physics Department, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran E-mail: shakeriz@iums. ac.ir Ultrasound is an exciting theranostic modality that plays a critical role in diagnostic and treatment of various diseases [1, 2]. Owing to its non-invasive nature, acceptable safety, low cost and easy handling, ultra...